New rare disease drugs firm Oranda seeks to raise up to €35m
Oranda’s co-founder and chief executive Ahmed Al-Derzi said the fledgling company is currently is in exclusive talks to finalise a licensing agreement for Europe, Middle East and Africa for ...
The Irish Times
3 days ago